<p>You are about to enter the B. Braun Melsungen AG (global) website. If you are from United States, visit the U. S. Website</p>

United States - B. Braun Medical Inc.

Australia - B. Braun Australia Pty. Ltd

<p>Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.</p>

Cancel

You have successfully logged out.

Clinical Value "Stent-less" PCI

SeQuent® Please vs. DES (EES) in de novo lesions

Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease

_{Nishiyama N et al. Int. J. Cardiol. 2016; 222; 113-8}

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professional before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.

Key findings

In the DCB group was not a single case of TLR reported (0.0 %), in contrast to the DES group with a TLR rate of 6.1 % at 8-month follow-up. The authors conclude that “stent-less” PCI could be useful with regards to the reduction of DAPT and a more safe discontinuation of DAPT than after DES implantation.

Description

Design: Randomized | Open-label | Prospective | Single center

Indication: De novo

Primary endpoint: TLR @ 8-month follow-up

Secondary endpoint: LLL @ 8-month follow-up

Results

Patients: 60 consecutive patients were enrolled in this trial and randomized into the DCB or DES group. After lesion preparation with NSE Alpha, three patients in the DCB group had an unacceptable angiographic result and were moved into the DES group. Therefore, a total of 27 patients were in the DCB group, 33 patients in the DES group.

Baseline characteristics: The two treatment groups were well balanced, there were no statistically significant differences between the two treatment groups.

Primary endpoint:

	DCB n = 27	DES n = 33	p-value
TLR	0.0 %	6.1 %	0.193

Secondary endpoint:

	DCB n = 27	DES n = 33	p-value
LLL	0.25 ± 0.25 mm	0.37 ± 0.40 mm	0.11

Further information on PubMed

Get in touch with our Coronary Drug Coated Balloon experts

Coronary Drug Coated Balloon contact form

Stay connected with My B. Braun

With your personalized account, your online experience will be easier, more comfortable and safe.

person_outline My B. Braun